UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-Term Prostate-Specific Antigen Stability and Predictive Factors of Failure After Permanent Seed Prostate Brachytherapy

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S137-S137

2016

Volltextzugriff (PDF)

Presenting stage and risk group in men dying of prostate cancer

Current oncology (Toronto), 2020-12, Vol.27 (6), p.e547-551

2020

Volltextzugriff (PDF)

Transvaginal Ultrasound-Guided Interstitial Brachytherapy for Vaginal Tumors: A Fixed Template Technique

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S502-S502

2014

Volltextzugriff (PDF)

A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery

Brachytherapy, 2018-05, Vol.17 (3), p.530-536

2018

Volltextzugriff (PDF)

A Retrospective Study Investigating the Use of the First Fraction CT-Based Treatment Planning to Deliver Subsequent Fractions for High-Dose-Rate (HDR) Brachytherapy of the Cervix

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E318-E319

2019

Volltextzugriff (PDF)

Human telomerase RNA-protein interactions

Nucleic acids research, 2001-08, Vol.29 (16), p.3385-3393

2001

Volltextzugriff (PDF)

Efficacy and Safety of Brachytherapy in Primary Vaginal Carcinoma

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e715-e716

2024

Volltextzugriff (PDF)

HDR Brachytherapy Boost for Unfavorable Localized Prostate Cancer: A Single Center Experience from Inception to Standard of Care

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e600-e600

2024

Volltextzugriff (PDF)

In Vivo Validation of Ultrasound (US)-based High-dose-rate (HDR) Prostate Brachytherapy (BT) Planning: Comparison of US Needle Tip Reconstruction to CT Gold Standard

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S378-S378

2012

Volltextzugriff (PDF)

OC-36 VALIDATION STUDY OF US-BASED HDR PROSTATE BRACHYTHERAPY PLANNING COMPARED TO CT GOLD STANDARD

Radiotherapy and oncology, 2012-05, Vol.103, p.S15-S15

2012

Volltextzugriff (PDF)

Comparison of Urethra Morphology on CT with Urinary Catheter and MRI without Urinary Catheter after Low Dose Rate Prostate Cancer Brachytherapy

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e585-e586

2024

Volltextzugriff (PDF)

OC-0359: Bladder volume variation reduces long-term toxicity of imageguided brachytherapy for cervical cancer

Radiotherapy and oncology, 2013-03, Vol.106, p.S140-S141

2013

Volltextzugriff (PDF)

A Randomized Comparison of Low Dose Rate or High Dose Rate Brachytherapy Combined with External Beam Radiation for Unfavorable Intermediate or High-Risk Prostate Cancer: Efficacy Results at Median 6 Years Follow Up

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S55-S56

2024

Volltextzugriff (PDF)

Poster — Thur Eve — 26: Cinical Implimentation of kV CBCT for Gynecological IMRT

Medical Physics, 2010-07, Vol.37 (7), p.3891-3891

2010

Volltextzugriff (PDF)

57 oral: HDR Brachytherapy Boost for Localized Prostate Cancer: Biochemical:Pathology Disease Free Survival and Toxicity Report

Radiotherapy and oncology, 2009-05, Vol.91, p.S19-S20

2009

Volltextzugriff (PDF)

Health-Related Quality of Life after Combined External Beam and Either High Dose Rate (HDR) or Low Dose Rate (LDR) Brachytherapy: Does the Rectal Dose from the LDR Brachytherapy Make a Difference?

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e369-e369

2023

Volltextzugriff (PDF)

PP-0161 mpMRI-guided dose escalation to DIL with US-planned HDR prostate brachytherapy: a phase II study

Radiotherapy and oncology, 2021-05, Vol.158, p.S124-S124

2021

Volltextzugriff (PDF)

A Randomized Phase III Trial Comparing Health-Related Quality of Life after Low Dose Rate (LDR) or High Dose Rate (HDR) Prostate Brachytherapy Boost Combined with External Beam Pelvic Radiotherapy (EBRT)

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S3-S4

2022

Volltextzugriff (PDF)

PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits

The EMBO journal, 2004-07, Vol.23 (13), p.2641-2650

2004

Volltextzugriff (PDF)

Looking Beyond D90: A Novel Way of Correlating Brachytherapy Quality With Local Control in Cervix Cancer

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e471-e471

2020

Volltextzugriff (PDF)

Cotranscriptional recruitment of the nuclear poly(A)-binding protein Pab2 to nascent transcripts and association with translating mRNPs

Nucleic acids research, 2009-06, Vol.37 (10), p.3418-3430

2009

Volltextzugriff (PDF)

Cervical Cancer Patient Reported Gastrointestinal Outcomes: Intensity/Volumetric Modulated vs. 3D Conformal Radiation Therapy

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e165-e165

2021

Volltextzugriff (PDF)

PD-0659: Looking Beyond D90: Correlating EUBED, gBEUD with Outcome in Cervical Cancer Brachytherapy

Radiotherapy and oncology, 2020-11, Vol.152, p.S366-S366

2020

Volltextzugriff (PDF)

RTOG/NRG 1115 Quality of Life of Phase III Dose Escalated Radiation Therapy (RT) and Standard Androgen Deprivation Therapy (ADT) with GnRH Agonist vs. Dose Escalated RT and ADT with GnRH Agonist and Orteronel (TAK-700) for Men with High-Risk Prostate

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e214

2022

Volltextzugriff (PDF)

Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) vs. Dose Escalated Radiation Therapy and Enhanced ADT with TAK-700 for Men with High-Risk Prostate Cancer (NRG Oncology/RTOG 1115)

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S67-S68

2022

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnalytical Letters

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(98)
Tagungsberichte
(2)

Sprache

Englisch
(97)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(45)
Humans
(31)
Male
(20)
Female
(19)
Biochemistry & Molecular Biology
(13)
Animals
(11)
Physical Sciences
(10)
Middle Aged
(9)
Biological And Medical Sciences
(8)
Chemistry
(8)
Cell Biology
(7)
Public, Environmental & Occupational Health
(7)
Aged
(6)
Endocrinology & Metabolism
(6)
Environmental Sciences
(6)
Environmental Sciences & Ecology
(6)
Hematology, Oncology And Palliative Medicine
(6)
Medical Sciences
(6)
Science & Technology - Other Topics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Long-Term Prostate-Specific Antigen Stability and Predictive Factors of Failure After Permanent Seed Prostate Brachytherapy

Presenting stage and risk group in men dying of prostate cancer

Transvaginal Ultrasound-Guided Interstitial Brachytherapy for Vaginal Tumors: A Fixed Template Technique

A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery

A Retrospective Study Investigating the Use of the First Fraction CT-Based Treatment Planning to Deliver Subsequent Fractions for High-Dose-Rate (HDR) Brachytherapy of the Cervix

Human telomerase RNA-protein interactions

Efficacy and Safety of Brachytherapy in Primary Vaginal Carcinoma

HDR Brachytherapy Boost for Unfavorable Localized Prostate Cancer: A Single Center Experience from Inception to Standard of Care

In Vivo Validation of Ultrasound (US)-based High-dose-rate (HDR) Prostate Brachytherapy (BT) Planning: Comparison of US Needle Tip Reconstruction to CT Gold Standard

OC-36 VALIDATION STUDY OF US-BASED HDR PROSTATE BRACHYTHERAPY PLANNING COMPARED TO CT GOLD STANDARD

Comparison of Urethra Morphology on CT with Urinary Catheter and MRI without Urinary Catheter after Low Dose Rate Prostate Cancer Brachytherapy

OC-0359: Bladder volume variation reduces long-term toxicity of imageguided brachytherapy for cervical cancer

A Randomized Comparison of Low Dose Rate or High Dose Rate Brachytherapy Combined with External Beam Radiation for Unfavorable Intermediate or High-Risk Prostate Cancer: Efficacy Results at Median 6 Years Follow Up

Poster — Thur Eve — 26: Cinical Implimentation of kV CBCT for Gynecological IMRT

57 oral: HDR Brachytherapy Boost for Localized Prostate Cancer: Biochemical:Pathology Disease Free Survival and Toxicity Report

Health-Related Quality of Life after Combined External Beam and Either High Dose Rate (HDR) or Low Dose Rate (LDR) Brachytherapy: Does the Rectal Dose from the LDR Brachytherapy Make a Difference?

PP-0161 mpMRI-guided dose escalation to DIL with US-planned HDR prostate brachytherapy: a phase II study

A Randomized Phase III Trial Comparing Health-Related Quality of Life after Low Dose Rate (LDR) or High Dose Rate (HDR) Prostate Brachytherapy Boost Combined with External Beam Pelvic Radiotherapy (EBRT)

PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits

Looking Beyond D90: A Novel Way of Correlating Brachytherapy Quality With Local Control in Cervix Cancer

Cotranscriptional recruitment of the nuclear poly(A)-binding protein Pab2 to nascent transcripts and association with translating mRNPs

Cervical Cancer Patient Reported Gastrointestinal Outcomes: Intensity/Volumetric Modulated vs. 3D Conformal Radiation Therapy

PD-0659: Looking Beyond D90: Correlating EUBED, gBEUD with Outcome in Cervical Cancer Brachytherapy

RTOG/NRG 1115 Quality of Life of Phase III Dose Escalated Radiation Therapy (RT) and Standard Androgen Deprivation Therapy (ADT) with GnRH Agonist vs. Dose Escalated RT and ADT with GnRH Agonist and Orteronel (TAK-700) for Men with High-Risk Prostate

Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) vs. Dose Escalated Radiation Therapy and Enhanced ADT with TAK-700 for Men with High-Risk Prostate Cancer (NRG Oncology/RTOG 1115)

Aktive Filter

Suchergebnisse filtern